Star Equity Holdings (Star Equity Holdings) Days Sales Outstanding

: 31.46 (As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

Star Equity Holdings's average Accounts Receivable for the three months ended in Dec. 2023 was $4.87 Mil. Star Equity Holdings's Revenue for the three months ended in Dec. 2023 was $14.11 Mil. Hence, Star Equity Holdings's Days Sales Outstanding for the three months ended in Dec. 2023 was 31.46.

The historical rank and industry rank for Star Equity Holdings's Days Sales Outstanding or its related term are showing as below:

STRR' s Days Sales Outstanding Range Over the Past 10 Years
Min: 31.68 Med: 51.5 Max: 75.96
Current: 45.54

During the past 13 years, Star Equity Holdings's highest Days Sales Outstanding was 75.96. The lowest was 31.68. And the median was 51.50.

STRR's Days Sales Outstanding is ranked better than
80.44% of 225 companies
in the Medical Diagnostics & Research industry
Industry Median: 69.32 vs STRR: 45.54

Star Equity Holdings's Days Sales Outstanding declined from Dec. 2022 (56.31) to Dec. 2023 (31.46).

Star Equity Holdings Days Sales Outstanding Historical Data

The historical data trend for Star Equity Holdings's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Star Equity Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

63.95

60.45

49.30

75.96

55.72

Star Equity Holdings Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding																56.31	40.78	98.45	34.62	31.46

Competitive Comparison

For the Diagnostics & Research subindustry, Star Equity Holdings's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Star Equity Holdings Days Sales Outstanding Distribution

For the Medical Diagnostics & Research industry and Healthcare sector, Star Equity Holdings's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Star Equity Holdings's Days Sales Outstanding falls into.

Star Equity Holdings Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Star Equity Holdings's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (7.975	+	6.004)	/	2 )	/	45.785	*	365
=	6.9895					/	45.785	*	365
=	55.72

Star Equity Holdings's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (3.727	+	6.004)	/	2 )	/	14.111	*	365 / 4
=	4.8655					/	14.111	*	365 / 4
=	31.46

Star Equity Holdings (NAS:STRR) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Star Equity Holdings Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Star Equity Holdings's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Star Equity Holdings (Star Equity Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Star Equity Holdings Inc (NAS:STRR) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

STRRP.PFD:USA

Address

53 Forest Avenue, Suite 101, Old Greenwich, CT, USA, 06870

Website

https://www.starequity.com

Star Equity Holdings Inc is a multi-industry diversified holding company with three segments; Healthcare segment provides products and services in the area of nuclear medicine imaging with a focus on cardiac health. It provides imaging services to healthcare providers using a fleet of solid-state gamma cameras and also the manufacturing, distribution, and maintenance of gamma cameras, The construction segment manufactures modular housing units for commercial and residential applications. It operates in two businesses: modular building manufacturing and structural wall panel and wood foundation manufacturing, including building supply retail operations, and The investments segment generates intercompany revenue from the lease of commercial properties and equipment.

Executives

Thatcher Butcher	officer: President - KBS	C/O STAR EQUITY HOLDINGS, INC., 53 FOREST AVENUE, SUITE 101, OLD GREENWICH CT 06870
Coleman Richard Kenneth Jr.	officer: Chief Operating Officer	53 FOREST AVE, SUITE 101, OLD GREENWICH CT 06870
Ronald A. Schumacher	officer: Exec Chairman - EdgeBuilder	C/O STAR EQUITY HOLDINGS, INC., 53 FOREST AVENUE, SUITE 101, OLD GREENWICH CT 06870
Jeffrey E. Eberwein	director	53 FOREST AVENUE, SUITE 101, OLD GREENWICH CT 06870
Mitchell I Quain	director	53 FOREST AVENUE, SUITE 101, OLD GREENWICH CT 06870
John W Gildea	director	53 FOREST AVENUE, SUITE 101, OLD GREENWICH CT 06870
Hannah M. Bible	officer: Chief Legal Officer	53 FOREST AVENUE, SUITE 101, OLD GREENWICH CT 06870
Michael A. Cunnion	director	53 FOREST AVENUE, SUITE 101, OLD GREENWICH CT 06870
David James Noble	officer: Chief Operating Officer	53 FOREST AVENUE, SUITE 101, OLD GREENWICH CT 06870
Matthew G. Molchan	officer: President and CEO	1048 INDUSTRIAL COURT, SUWANEE GA 30024
Cannell Capital Llc	10 percent owner	245 MERIWETHER CIRCLE, ALTA WY 83414
John M Climaco	director	PO BOX 326, PARK CITY UT 84060
Virgil Lott	officer: President, Diagnostic Imaging	1048 INDUSTRIAL COURT, SUWANEE GA 30024
Michael Debeauvernet	officer: General Manager,Mobile Imaging	C/O DIGIRAD CORPORATION, 1048 INDUSTRIAL COURT, SUWANEE GA 30024
Jeffry R. Keyes	officer: Chief Financial Officer	13950 STOWE DRIVE, POWAY CA 92064-8803